NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)

ADAM17 activation in circulating neutrophils following bacterial challenge impairs their recruitment

(2012) C. Long et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism

(2011) S. Veeramani et al.   BLOOD

The impact of Fc-  receptor polymorphisms in elderly patients with diffuse large B-cell lymphoma treated with CHOP with or without rituximab

(2011) M. Ahlgrimm et al.   BLOOD

Different Signaling Pathways Stimulate a Disintegrin and Metalloprotease-17 (ADAM17) in Neutrophils during Apoptosis and Activation

(2011) Yue Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Leukemic Priming of Resting NK Cells Is Killer Ig-like Receptor Independent but Requires CD15-Mediated CD2 Ligation and Natural Cytotoxicity Receptors

(2011) M. Sabry et al.   JOURNAL OF IMMUNOLOGY

Molecular Mechanisms of Natural Killer Cell Activation

(2011) Yenan T. Bryceson et al.   Journal of Innate Immunity

Leukocyte ADAM17 Regulates Acute Pulmonary Inflammation

(2011) Patrick G. Arndt et al.   PLoS One

Cross-domain inhibition of TACE ectodomain

(2011) C. J. Tape et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

ADAM17: a molecular switch to control inflammation and tissue regeneration

(2011) Jürgen Scheller et al.   TRENDS IN IMMUNOLOGY

Rituximab

(2010) Gillian M. Keating   DRUGS

In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli -mediated peritonitis

(2010) Chunmei Long et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Regulation of human NK-cell cytokine and chemokine production by target cell recognition

(2009) C. Fauriat et al.   BLOOD

ADAM17 as a Therapeutic Target in Multiple Diseases

(2009) Joaquin Arribas et al.   CURRENT PHARMACEUTICAL DESIGN

Tissue-Specific Homing and Expansion of Donor NK Cells in Allogeneic Bone Marrow Transplantation

(2009) J. A. Olson et al.   JOURNAL OF IMMUNOLOGY

NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model

(2009) N. T. Joncker et al.   JOURNAL OF IMMUNOLOGY

Matrix Metalloprotease Inhibitors Restore Impaired NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Human Immunodeficiency Virus Type 1 Infection

(2009) Q. Liu et al.   JOURNAL OF VIROLOGY

Potent, exceptionally selective, orally bioavailable inhibitors of TNF-α Converting Enzyme (TACE): Novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1′ substituents

(2008) Gregory R. Ott et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells

(2008) P. Brodin et al.   BLOOD

MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response

(2008) M. Yawata et al.   BLOOD

Up on the tightrope: natural killer cell activation and inhibition

(2008) Lewis L Lanier   NATURE IMMUNOLOGY